238 related articles for article (PubMed ID: 16597712)
1. A selective p38 alpha mitogen-activated protein kinase inhibitor reverses cartilage and bone destruction in mice with collagen-induced arthritis.
Medicherla S; Ma JY; Mangadu R; Jiang Y; Zhao JJ; Almirez R; Kerr I; Stebbins EG; O'Young G; Kapoun AM; Luedtke G; Chakravarty S; Dugar S; Genant HK; Protter AA
J Pharmacol Exp Ther; 2006 Jul; 318(1):132-41. PubMed ID: 16597712
[TBL] [Abstract][Full Text] [Related]
2. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction.
Mbalaviele G; Anderson G; Jones A; De Ciechi P; Settle S; Mnich S; Thiede M; Abu-Amer Y; Portanova J; Monahan J
J Pharmacol Exp Ther; 2006 Jun; 317(3):1044-53. PubMed ID: 16501068
[TBL] [Abstract][Full Text] [Related]
4. Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction.
Zwerina J; Hayer S; Redlich K; Bobacz K; Kollias G; Smolen JS; Schett G
Arthritis Rheum; 2006 Feb; 54(2):463-72. PubMed ID: 16447221
[TBL] [Abstract][Full Text] [Related]
5. META060 inhibits osteoclastogenesis and matrix metalloproteinases in vitro and reduces bone and cartilage degradation in a mouse model of rheumatoid arthritis.
Konda VR; Desai A; Darland G; Bland JS; Tripp ML
Arthritis Rheum; 2010 Jun; 62(6):1683-92. PubMed ID: 20201075
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.
Hope HR; Anderson GD; Burnette BL; Compton RP; Devraj RV; Hirsch JL; Keith RH; Li X; Mbalaviele G; Messing DM; Saabye MJ; Schindler JF; Selness SR; Stillwell LI; Webb EG; Zhang J; Monahan JB
J Pharmacol Exp Ther; 2009 Dec; 331(3):882-95. PubMed ID: 19720877
[TBL] [Abstract][Full Text] [Related]
7. Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity.
Hill RJ; Dabbagh K; Phippard D; Li C; Suttmann RT; Welch M; Papp E; Song KW; Chang KC; Leaffer D; Kim YN; Roberts RT; Zabka TS; Aud D; Dal Porto J; Manning AM; Peng SL; Goldstein DM; Wong BR
J Pharmacol Exp Ther; 2008 Dec; 327(3):610-9. PubMed ID: 18776065
[TBL] [Abstract][Full Text] [Related]
8. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
[TBL] [Abstract][Full Text] [Related]
9. Suppressive effects of PG201, an ethanol extract from herbs, on collagen-induced arthritis in mice.
Shin SS; Jin M; Jung HJ; Kim B; Jeon H; Choi JJ; Kim JM; Cho BW; Chung SH; Lee YW; Song YW; Kim S
Rheumatology (Oxford); 2003 May; 42(5):665-72. PubMed ID: 12709543
[TBL] [Abstract][Full Text] [Related]
10. The alpha-isoform of p38 MAPK specifically regulates arthritic bone loss.
Böhm C; Hayer S; Kilian A; Zaiss MM; Finger S; Hess A; Engelke K; Kollias G; Krönke G; Zwerina J; Schett G; David JP
J Immunol; 2009 Nov; 183(9):5938-47. PubMed ID: 19828631
[TBL] [Abstract][Full Text] [Related]
11. A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss.
Kirkwood KL; Li F; Rogers JE; Otremba J; Coatney DD; Kreider JM; D'Silva NJ; Chakravarty S; Dugar S; Higgins LS; Protter AA; Medicherla S
J Pharmacol Exp Ther; 2007 Jan; 320(1):56-63. PubMed ID: 17041006
[TBL] [Abstract][Full Text] [Related]
12. Triptolide, a diterpenoid triepoxide, suppresses inflammation and cartilage destruction in collagen-induced arthritis mice.
Lin N; Liu C; Xiao C; Jia H; Imada K; Wu H; Ito A
Biochem Pharmacol; 2007 Jan; 73(1):136-46. PubMed ID: 17097618
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase.
Chopra P; Kulkarni O; Gupta S; Bajpai M; Kanoje V; Banerjee M; Bansal V; Visaga S; Chatterjee M; Chaira T; Shirumalla RK; Verma AK; Dastidar SG; Sharma G; Ray A
Int Immunopharmacol; 2010 Apr; 10(4):467-73. PubMed ID: 20093202
[TBL] [Abstract][Full Text] [Related]
14. Treatment with anti-gamma-glutamyl transpeptidase antibody attenuates osteolysis in collagen-induced arthritis mice.
Ishizuka Y; Moriwaki S; Kawahara-Hanaoka M; Uemura Y; Serizawa I; Miyauchi M; Shibata S; Kanaya T; Takata T; Taniguchi N; Niida S
J Bone Miner Res; 2007 Dec; 22(12):1933-42. PubMed ID: 17680722
[TBL] [Abstract][Full Text] [Related]
15. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
[TBL] [Abstract][Full Text] [Related]
16. THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis.
Tomita T; Kakiuchi Y; Tsao PS
Arthritis Res Ther; 2006; 8(1):R7. PubMed ID: 16356194
[TBL] [Abstract][Full Text] [Related]
17. Tenosynovitis and osteoclast formation as the initial preclinical changes in a murine model of inflammatory arthritis.
Hayer S; Redlich K; Korb A; Hermann S; Smolen J; Schett G
Arthritis Rheum; 2007 Jan; 56(1):79-88. PubMed ID: 17195210
[TBL] [Abstract][Full Text] [Related]
18. Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: potential proinflammatory mechanisms.
Thiel MJ; Schaefer CJ; Lesch ME; Mobley JL; Dudley DT; Tecle H; Barrett SD; Schrier DJ; Flory CM
Arthritis Rheum; 2007 Oct; 56(10):3347-57. PubMed ID: 17907188
[TBL] [Abstract][Full Text] [Related]
19. p38 MAPK as a potential therapeutic target for inflammatory osteolysis.
Wei S; Siegal GP
Adv Anat Pathol; 2007 Jan; 14(1):42-5. PubMed ID: 17198310
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of a traditional Chinese herbal formula TBL-II on type II collagen-induced arthritis in mice.
Shen X; Li C; Zhao H; Li S; Chen J; Kobayashi Y; Shen W
J Ethnopharmacol; 2011 Mar; 134(2):399-405. PubMed ID: 21215307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
